Biomarkers in endometriosis

In: Ginecologia.ro · 2020 · vol. 1(27) , pp. 30 · doi:10.26416/gine.27.1.2020.2887 · W3014177738
article OA: diamond CC0
AI-generated summary by claude@2026-06, 2026-06-08

This review discusses the current status of plasma, urine, peritoneal fluid, and endometrial biomarkers for the noninvasive diagnosis of endometriosis, a debilitating condition affecting 10% of reproductive-age women.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Estimated to affect about 10% of women of reproductive age, endometriosis represents a debilitating disease. Endometriosis is characterized by endometrial tissue implants in extrauterine locations. Laparoscopy represents the gold standard for the diagnosis of endometriosis. Noninvasive diagnosis of endometriosis remains an interesting field for research. In our review, we describe and discuss the current status of biomarkers of endometriosis in plasma, urine, peritoneal fluid and endometrium.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (18)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK